药学与生物科学学院
设为首页 | 加入收藏

首页 | 学院概况 | 本科生教育 | 研究生教育 | 科学研究 | 学科建设 | 党建群团 | 学生工作 | 招生就业 | 校友之窗

 
  热点新闻
 
  当前位置:新闻详细页  
 
硕士生导师-喻翠云
2019-03-25 10:39     (点击: )

喻翠云,出生于197810月,土家族,中共党员,南华大学教授,博士研究生导师,留美归国学者,现任南华大学药学院院长,兼任新型抗体药物及其智能运输系统湖南省重点实验室副主任。先后荣获“湖南省三八红旗手”、 “湖南省最美科技工作者”、湖南省自然科学杰出青年基金和湖南省委组织部优秀中青年专家等荣誉,入选第二轮高层次卫生人才“225”工程——湖南省医学学科带头人、湖南省医学学科骨干人才、江苏省江海英才计划、南华大学船山人才工程和南华大学首批青年英才计划主持国家科技部重点研发计划项目课题1项,先后承担国家自然科学基金(含青年基金)2项、湖南省自然科学基金杰出青年基金1项等。在学术任职方面,担任中国抗癌协会肿瘤微环境专业委员会委员、国家自然科学基金委员会评审专家、教育部评审专家、湖南省科技厅评审专家、南华大学“十二五”和“十三五”抗肿瘤药物研发科技创新团队牵头人、南华大学学术委员会委员,任Current Topics in Medicinal Chemistry 杂志(SCI)客座主编等。主要创新性成果已经以第一作者/通讯作者身份在国际主流期刊如《ACS Applied Materials & Interfaces》、《Acta Biomaterialia》、《Molecular Pharmaceutics》等,累计以第一或通讯作者发表被SCI收录30多篇,经检索《ISI Web of Science》累计被引用逾600次。编写专著7部,其中主编SCI期刊2期,副主编教材、专著各1部,参编3部。


近几年主持的科研项目课题

1、国家重点研发计划课题,2018YFB190020 1,放射性废液膜蒸馏处理装置研制应用, 2019/04-2023/032895万元,在研,主持。

2、湖南省自然科学杰出青年基金,2017JJ1024,生长抑素类似物修饰果胶-阿霉素纳米药物传递体系抗肝癌作用机制研究,2017/01-2019/1230万元,在研,主持。

3、国家自然科学基金项目,81471777,肝癌细胞靶向性药物与miR-122共传输体系及其协同抗肿瘤作用机制研究,2015/01-2018/1272万元,已结题,主持。

4、湖南省科学技术厅课题,2014GK3082,用于5-FUMiR-122共传输的半乳糖化壳聚糖基纳米药物载体研究,2014/01-2015/095万元,已结题,主持。

5、国家自然科学基金项目,81102409,肝癌靶向性果胶基纳米载药体系的研究,2012/01-2014/1220万元,已结题,主持。

6、湖南省教育厅项目,10C1179,肝癌靶向性纳米药物体外筛选研究,2011/01-2013/121万元,已结题,主持。


三年以通讯作者(含共同通讯作者)发表部分学术论文

[1] Cheng-Hui Xu , Peng-Ju Yeab,Yang-Chun Zhou , Dong-Xiu Hea, Hua Wei *,Cui-Yun Yu*.(通讯作者)Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy. Acta Biomaterialia. 2020, 105, 1-14. (SCI, IF=6.638, JCR 1区)

[2] Mingqi Wang, Jinrong Long,Simin Zhang, Fangjun Liu, Xiaolong Zhang, Xianshuo Zhang, Lu Sun, Liwei Ma, Cuiyun Yu*(通讯作者)and Hua Wei*.Folate-Targeted Anticancer Drug Delivery via a Combination Strategy of a Micelle Complex and Reducible Conjugation. ACS Biomater. Sci. Eng. 2020, 6, 1565-1572. (SCI, IF=4.511, JCR 2区)

[3] Qian Ning, Yu-Feng Liu, Peng-Ju Ye, Pei Gao,Zhi-Ping Li ,SiYue Tang,Dong-Xiu He, Sheng-Song Tang,Hua Wei*and Cui-Yun Yu*.(通讯作者)Delivery of Liver Specific miRNA-122 Using a Targeted Macromolecular Prodrug Toward Synergistic Therapy For Hepatocellular Carcinoma.ACS Applied Materials & Interfaces.2019, 11(11):10578-10588. (SCI, IF=8.456, JCR 1区)

[4] Guiying Kang, Lu Sun, Yuping Liu,Chao Meng, Wei Ma, Baoyan Wang, Liwei Ma, Cuiyun Yu*(通讯作者)and Hua Wei*.Micelles with cyclic poly(#-caprolactone) moieties: greater stability, larger drug loading capacity, and slower degradation property for controlled drug release.Langmuir. 2019, 35, 12509−12517(SCI, IF=3.683, JCR 2区)

[5] Xianshuo Zhangb Fangjun Liu, Xiaochen Li, Yunfei Tian, Liwei Ma, Cuiyun Yu* (通讯作者)and Hua Wei*.The fabrication of hybrid micelles with enhanced permeability for drug delivery via a diethoxymethylsilyl-based crosslinking strategy .Polym. Chem., 2019, 10,4529(SCI, IF=4.76, JCR 1区)

[6] Huaxin Tan, Taoyu Wang, Yaru Shao, Cuiyun Yu*(通讯作者) and Lidan Hu*.Crucial Breakthrough of Functional Persistent Luminescence Materials for Biomedical and Information Technological Applications. Frontiers in Chemistry. 2019,7:387 (SCI, IF=3.782, JCR 2区)

[7] Xiaolong Zhang, Qi Hua, Pina Meng, Minggi Wang,Yunfei Wang, Lu Sun,Liwei Ma, Baoyan Wang, Cuiyun Yu* (通讯作者)and Hua Wei *.Fabrication of Biocleavable Crosslinked Polyprodrug Vesicles via Reversible Donor-Acceptor Interactions for Enhanced Anticancer Drug Delivery. Polym.Chem. 2019,21(10: 2666-2673. (SCI, IF=4.76, JCR 1区)

[8] Peng-Ju Ye, Can Huang, Sa Yang, Pei Gao, Zhi-Ping Li, Si-Yue Tang, Ya Xiang, Yu-Feng Liu, Yu-Ping Chen, Dong-Xiu He & Cui-Yun Yu* (通讯作者). Facile fabrication of a novel hybrid nanoparticles by self-assembling based on pectin-doxorubicin conjugates for hepatocellular carcinoma therapy. Artificial Cells, Nanomedicine, and Biotechnology. 2018, 46(S3): 628-637. (SCI, IF=4.462, JCR 2)

[9] Zhi-Ping Li, Ming-Chao Jiang, Bo Chen, Pei Gao, Sa Yang, Yu-Feng Liu, Peng-Ju Ye, Dong-Xiu He, Hong-Lin Huang, Cui-Yun Yu* (通讯作者). Fabrication and Characterization of a Novel Self-Assembling Micelle Based on Chitosan Cross-Linked Pectin-Doxorubicin Conjugates Macromolecular Pro-Drug for Targeted Cancer Therapy. RSC Advances.2018, 8:12004-12016. (SCI, IF=3.049, JCR 3)

[10] Can Huang, Na-Mei Li, Pei Gao, Sa Yang, Qian Ning, Wen Huang, Zhi-Ping Li,Peng-Ju Ye, Li Xiang, Dong-Xiu He, Xiang-Wen Tan and Cui-Yun Yu* (通讯作者). In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy. Drug Delivery. 2017, 24(1): 459-466. (SCI, IF=3.829, JCR 1)



关闭窗口
   
 
 
 网站地图 | 南华大学 | 联系我们 | 校友之家 

南华大学药学院 地址:中国 湖南 衡阳 常胜西路28号
电话:0734-8281408  邮编:421001
ICP备案号:湘教QS3-200504-000019 湘ICP备11003720